Your reading list

Patent ruling upsets biotech

By 
Reading Time: < 1 minute

Published: December 19, 2002

The Supreme Court has thrown a wrench into the gears of Canada’s

biotechnology industry, says a prominent promoter of agricultural

biotechnology.

And he doubts that the federal government will rush to play mechanic.

“There are a lot of other issues to deal with, and people aren’t

marching in the streets about this one,” said Allan McHughen, a

University of California biotechnology professor and former plant

breeder at the University of Saskatchewan.

The court recently ruled that a genetically modified mouse could not be

Read Also

Two combines, one in front of the other, harvest winter wheat.

China’s grain imports have slumped big-time

China purchased just over 20 million tonnes of wheat, corn, barley and sorghum last year, that is well below the 60 million tonnes purchased in 2021-22.

given a patent. The process of creating the original mouse at a

cellular level is patentable, the court said, but that patent does not

extend to live mice.

McHughen said the court’s ruling has rattled the industry because

biotech companies are unsure what can be patented. The court disallowed

patents for “higher life forms,” but said lower life forms could be

patented. It did not, however, show where the dividing line between

higher and lower life forms lies, saying that is the role of Parliament

to clarify.

This lack of clarity is dangerous, said McHughen.

“Uncertainty is always anxiety-inducing,” said McHughen.

“People who are investing in research don’t like uncertainty.”

McHughen said companies won’t know where to focus their research unless

the dividing line between patentable and non-patentable life forms

exists.

“At least you would know what the rules are.

“I’m sure many of these firms, large and small, could deal with a very

decisive position, whatever the government declares, because then

people would know where to put their money.”

McHughen said companies that wanted to invest in research that would

require patenting plants or animals will probably move to another

country if the government declared that these life forms could not be

patented.

These companies might also stay in Canada but switch their research to

an area that the government declared could be protected by patent law.

About the author

Ed White

Ed White

Markets at a glance

explore

Stories from our other publications